Received Feb 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
administration of Engerix B 10 mcg to the adult patient; administration of Engerix B 10 mcg to the adult patient; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of underdose in a adult patient who received HBV (Engerix B 10 mcg) for prophylaxis. On 22-JAN-2026, the patient received the 1st dose of Engerix B 10 mcg. On 22-JAN-2026, an unknown time after receiving Engerix B 10 mcg, the patient experienced underdose (Verbatim: administration of Engerix B 10 mcg to the adult patient) and adult use of a child product (Verbatim: administration of Engerix B 10 mcg to the adult patient). The outcome of the underdose and adult use of a child product were not applicable. Additional Information: GSK Receipt Date: 27-JAN-2026 The batch number was not provided and a request for this information had been made.